Amedeo Smart

Free Medical Literature Service



Multiple Sclerosis

  Free Subscription

Articles published in
    April 2024
  1. HUANG J, Tengvall K, Bomfim Lima I, Hedstrom AK, et al
    Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.
    Brain. 2024 Apr 17:awae110. doi: 10.1093.
    >> Share

    March 2024
  2. MAINERO C, Miscioscia A, Treaba CA
    Cortical remyelination in multiple sclerosis: a target for disease monitoring and intervention.
    Brain. 2024 Mar 27:awae083. doi: 10.1093.
    >> Share

    January 2024
  3. HERRANZ E, Treaba CA, Barletta VT, Mehndiratta A, et al
    Characterization of cortico-meningeal translocator protein expression in multiple sclerosis.
    Brain. 2024 Jan 30:awae030. doi: 10.1093.
    >> Share

  4. LAZZAROTTO A, Hamzaoui M, Tonietto M, Dubessy AL, et al
    Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis.
    Brain. 2024 Jan 24:awae024. doi: 10.1093.
    >> Share

  5. BAGNATO F, Sati P, Hemond CC, Elliott C, et al
    Imaging chronic active lesions in multiple sclerosis: a consensus statement.
    Brain. 2024 Jan 16:awae013. doi: 10.1093.
    >> Share

    Transcriptomics reveals CSF cellular composition in multiple sclerosis but detects no viral RNA.
    Brain. 2024 Jan 5:awae006. doi: 10.1093.
    >> Share

  7. JAMANN H, Desu HL, Cui QL, Halaweh A, et al
    ALCAM on human oligodendrocytes mediates CD4 T cell adhesion.
    Brain. 2024;147:147-162.
    >> Share

    December 2023
  8. MARZIALI LN, Hwang Y, Palmisano M, Cuenda A, et al
    p38gamma MAPK delays myelination and remyelination and is abundant in multiple sclerosis lesions.
    Brain. 2023 Dec 21:awad421. doi: 10.1093.
    >> Share

  9. CALLEGARI I, Oechtering J, Schneider M, Perriot S, et al
    Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5.
    Brain. 2023 Dec 20:awad424. doi: 10.1093.
    >> Share

  10. CREE BAC
    Herpes viral infection and the multiple sclerosis prodrome: is HHV-6A infection a second hit?
    Brain. 2023 Dec 18:awad418. doi: 10.1093.
    >> Share

  11. BUTZKUEVEN H, Ponsonby AL, Stein MS, Lucas RM, et al
    Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.
    Brain. 2023 Dec 12:awad409. doi: 10.1093.
    >> Share

  12. BAN M, Bredikhin D, Huang Y, Bonder MJ, et al
    Expression profiling of cerebrospinal fluid identifies dysregulated antiviral mechanisms in multiple sclerosis.
    Brain. 2023 Dec 1:awad404. doi: 10.1093.
    >> Share

    November 2023
  13. KEDDIE S, Smyth D, Keh RYS, Chou MKL, et al
    Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
    Brain. 2023;146:4562-4573.
    >> Share

    October 2023
  14. GRUT V, Bistrom M, Salzer J, Stridh P, et al
    Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.
    Brain. 2023 Oct 31:awad374. doi: 10.1093.
    >> Share

  15. BERNARD HEALEY SA, Giovannoni G, Noyce A, Dobson R, et al
    Impact of multiple sclerosis risk alleles on the plasma proteome.
    Brain. 2023 Oct 18:awad363. doi: 10.1093.
    >> Share

    September 2023
  16. MATSUMOTO Y, Kaneko K, Takahashi T, Takai Y, et al
    Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids.
    Brain. 2023;146:3938-3948.
    >> Share

    August 2023
  17. FLEISCHER V, Gonzalez-Escamilla G, Pareto D, Rovira A, et al
    Prognostic value of single-subject grey matter networks in early multiple sclerosis.
    Brain. 2023 Aug 29:awad288. doi: 10.1093.
    >> Share

  18. LEBRUN-FRENAY C, Okuda DT, Siva A, Landes-Chateau C, et al
    The radiologically isolated syndrome: revised diagnostic criteria.
    Brain. 2023;146:3431-3443.
    >> Share

    June 2023
  19. SHARMIN S, Roos I, Simpson-Yap S, Malpas C, et al
    The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
    Brain. 2023 Jun 27:awad218. doi: 10.1093.
    >> Share

  20. HENRIET E, Martin EM, Jubin P, Langui D, et al
    Monitoring recovery after CNS demyelination, a novel tool to de-risk pro-remyelinating strategies.
    Brain. 2023;146:2453-2463.
    >> Share

  21. CORTESE R, Battaglini M, Prados F, Bianchi A, et al
    Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
    Brain. 2023;146:2489-2501.
    >> Share

    April 2023
  22. CHARABATI M, Zandee S, Fournier AP, Tastet O, et al
    MCAM+ brain endothelial cells contribute to neuroinflammation by recruiting pathogenic CD4+ T lymphocytes.
    Brain. 2023;146:1483-1495.
    >> Share

  23. GUO Y, Lennon VA
    A distinctive IgG-mediated pathogenesis for primary progressive multiple sclerosis?
    Brain. 2023 Apr 3:awad107. doi: 10.1093.
    >> Share

    March 2023
  24. LIN J, Zhou J, Xu Y
    Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.
    Brain. 2023 Mar 2:awad070. doi: 10.1093.
    >> Share

    February 2023
  25. WONG JK, Lin J, Kung NJ, Tse AL, et al
    Cerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenic.
    Brain. 2023 Feb 3:awad031. doi: 10.1093.
    >> Share

    December 2022
  26. NIJ BIJVANK JA, Hof SN, Prouskas SE, Schoonheim MM, et al
    A novel eye-movement impairment in multiple sclerosis indicating wide-spread cortical damage.
    Brain. 2022 Dec 20:awac474. doi: 10.1093.
    >> Share

  27. JAMES BATES RE, Browne E, Schalks R, Jacobs H, et al
    Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration.
    Brain. 2022;145:4287-4307.
    >> Share

  28. PISA M, Pansieri J, Yee S, Ruiz J, et al
    Anterior optic pathway pathology in CNS demyelinating diseases.
    Brain. 2022;145:4308-4319.
    >> Share

    November 2022
  29. JOKUBAITIS VG, Campagna MP, Ibrahim O, Stankovich J, et al
    Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity.
    Brain. 2022 Nov 30:awac449. doi: 10.1093.
    >> Share

    Location, location, location: myelin repair and proximity to ventricular CSF in multiple sclerosis.
    Brain. 2022 Nov 30:awac448. doi: 10.1093.
    >> Share

  31. ARRAMBIDE G, Espejo C, Carbonell-Mirabent P, Dieli-Crimi R, et al
    The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria.
    Brain. 2022;145:3931-3942.
    >> Share

  32. CORDANO C, Sin JH, Timmons G, Yiu HH, et al
    Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy.
    Brain. 2022;145:3943-3952.
    >> Share

  33. LIN X, Yang Y, Gresle M, Cuellar-Partida G, et al
    Novel plasma and brain proteins that are implicated in multiple sclerosis.
    Brain. 2022 Nov 8. pii: 6809197. doi: 10.1093.
    >> Share

  34. GARTON T, Gill AJ, Calabresi PA
    Distinct mechanisms of oligodendrocyte injury inform therapeutic interventions in multiple sclerosis.
    Brain. 2022 Nov 3. pii: 6794531. doi: 10.1093.
    >> Share

  35. ROSTGAARD K, Nielsen NM, Melbye M, Frisch M, et al
    Siblings reduce multiple sclerosis risk by preventing delayed primary Epstein-Barr virus infection.
    Brain. 2022 Nov 1. pii: 6783238. doi: 10.1093.
    >> Share

    September 2022
  36. TONIETTO M, Poirion E, Lazzarotto A, Ricigliano V, et al
    Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration.
    Brain. 2022 Sep 13. pii: 6696508. doi: 10.1093.
    >> Share

  37. TEPAVCEVIC V, Lubetzki C
    Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
    Brain. 2022 Sep 12. pii: 6696052. doi: 10.1093.
    >> Share

    July 2022
  38. BHARGAVA P, Hartung HP, Calabresi PA
    Contribution of B cells to cortical damage in multiple sclerosis.
    Brain. 2022 Jul 1. pii: 6623951. doi: 10.1093.
    >> Share

    June 2022
  39. DADAR M, Mahmoud S, Narayanan S, Collins DL, et al
    Diffusely abnormal white matter converts to T2 lesion volume in the absence of MRI-detectable acute inflammation.
    Brain. 2022;145:2008-2017.
    >> Share

  40. MADSEN MAJ, Wiggermann V, Marques MFM, Lundell H, et al
    Linking lesions in sensorimotor cortex to contralateral hand function in multiple sclerosis: a 7 T MRI study.
    Brain. 2022 Jun 2. pii: 6599027. doi: 10.1093.
    >> Share

    May 2022
  41. EISSMAN JM, Dumitrescu L, Mahoney ER, Smith AN, et al
    Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585174. doi: 10.1093.
    >> Share

    March 2022
  42. PORTACCIO E, Bellinvia A, Fonderico M, Pasto L, et al
    Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.
    Brain. 2022 Mar 24. pii: 6553893. doi: 10.1093.
    >> Share

  43. SHAMS H, Shao X, Santaniello A, Kirkish G, et al
    Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans.
    Brain. 2022 Mar 7. pii: 6542574. doi: 10.1093.
    >> Share

    February 2022
  44. PERNIN F, Luo J, Cui QL, Blain M, et al
    Diverse injury responses of human oligodendrocyte to mediators implicated in multiple sclerosis.
    Brain. 2022 Feb 24. pii: 6535861. doi: 10.1093.
    >> Share

  45. LUBLIN FD, Haring DA, Ganjgahi H, Ocampo A, et al
    How patients with multiple sclerosis acquire disability.
    Brain. 2022 Feb 1. pii: 6519354. doi: 10.1093.
    >> Share

    January 2022
  46. NISHIHARA H, Perriot S, Gastfriend BD, Steinfort M, et al
    Intrinsic blood-brain barrier dysfunction contributes to multiple sclerosis pathogenesis.
    Brain. 2022 Jan 27. pii: 6516047. doi: 10.1093.
    >> Share

    December 2021
  47. GREEN AJ
    Socioeconomic disadvantage in multiple sclerosis: does inequality act on the substrate for disability?
    Brain. 2021 Dec 20. pii: 6470562. doi: 10.1093.
    >> Share

  48. CAROTENUTO A, Cacciaguerra L, Pagani E, Preziosa P, et al
    Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability.
    Brain. 2021 Dec 17. pii: 6469024. doi: 10.1093.
    >> Share

  49. NTRANOS A, Park HJ, Wentling M, Tolstikov V, et al
    Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma.
    Brain. 2021 Dec 11. pii: 6459638. doi: 10.1093.
    >> Share

    November 2021
  50. LIEBMANN M, Korn L, Janoschka C, Albrecht S, et al
    Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity.
    Brain. 2021;144:3126-3141.
    >> Share

    October 2021
  51. VASILEIOU ES, Filippatou AG, Pimentel Maldonado D, Kalaitzidis G, et al
    Socioeconomic disparity is associated with faster retinal neurodegeneration in multiple sclerosis.
    Brain. 2021 Oct 29. pii: 6414110. doi: 10.1093.
    >> Share

  52. RODGERS J, Friede T, Vonberg FW, Constantinescu CS, et al
    The impact of smoking cessation on multiple sclerosis disease progression.
    Brain. 2021 Oct 8. pii: 6384574. doi: 10.1093.
    >> Share

    June 2021
  53. BITTNER S, Oh J, Havrdova EK, Tintore M, et al
    The potential of serum neurofilament as biomarker for multiple sclerosis.
    Brain. 2021 Jun 28. pii: 6310737. doi: 10.1093.
    >> Share

  54. COLLORONE S, Prados F, Kanber B, Cawley NM, et al
    Brain microstructural and metabolic alterations detected in vivo at onset of the first demyelinating event.
    Brain. 2021;144:1409-1421.
    >> Share

  55. HAIDER L, Prados F, Chung K, Goodkin O, et al
    Cortical involvement determines impairment 30 years after a clinically isolated syndrome.
    Brain. 2021;144:1384-1395.
    >> Share

    May 2021
  56. GRANZIERA C, Wuerfel J, Barkhof F, Calabrese M, et al
    Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis.
    Brain. 2021 May 10. pii: 6273092. doi: 10.1093.
    >> Share

    April 2021
  57. FLECK AK, Hucke S, Teipel F, Eschborn M, et al
    Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity.
    Brain. 2021 Apr 26. pii: 6252379. doi: 10.1093.
    >> Share

  58. GHORBANI S, Yong VW
    The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis.
    Brain. 2021 Apr 23. pii: 6247173. doi: 10.1093.
    >> Share

  59. PARDINI M, Brown JWL, Magliozzi R, Reynolds R, et al
    Surface-in pathology in multiple sclerosis: a new view on pathogenesis?
    Brain. 2021 Apr 20. pii: 6238675. doi: 10.1093.
    >> Share

  60. PISA M, Croese T, Dalla Costa G, Guerrieri S, et al
    Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes.
    Brain. 2021 Apr 8. pii: 6215108. doi: 10.1093.
    >> Share

    March 2021
  61. ONTANEDA D, Raza PC, Mahajan KR, Arnold DL, et al
    Deep grey matter injury in multiple sclerosis: A NAIMS consensus statement.
    Brain. 2021 Mar 23. pii: 6184142. doi: 10.1093.
    >> Share

  62. SABEL CE, Pearson JF, Mason DF, Willoughby E, et al
    The latitude gradient for multiple sclerosis prevalence is established in the early lifecourse.
    Brain. 2021 Mar 11. pii: 6168130. doi: 10.1093.
    >> Share

  63. RAHMANZADEH R, Lu PJ, Barakovic M, Weigel M, et al
    Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging.
    Brain. 2021 Mar 9. pii: 6164965. doi: 10.1093.
    >> Share

  64. XU Y, Smith KA, Hiyoshi A, Piehl F, et al
    Hospital-diagnosed infections before age 20 and risk of a subsequent multiple sclerosis diagnosis.
    Brain. 2021 Mar 9. pii: 6164964. doi: 10.1093.
    >> Share

    February 2021
  65. KILPATRICK TJ, Binder MD
    Neuregulin therapy for multiple sclerosis: an each-way bet?
    Brain. 2021;144:6-8.
    >> Share

    January 2021
  66. DAL-BIANCO A, Grabner G, Kronnerwetter C, Weber M, et al
    Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI.
    Brain. 2021 Jan 23. pii: 6114694. doi: 10.1093.
    >> Share

  67. Corrigendum to: Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis.
    Brain. 2021 Jan 11. pii: 6082765. doi: 10.1093.
    >> Share

    December 2020
  68. KIM K, Probstel AK, Baumann R, Dyckow J, et al
    Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis.
    Brain. 2020 Dec 29. pii: 6055080. doi: 10.1093.
    >> Share

  69. HALDER SK, Milner R
    Hypoxia in multiple sclerosis; is it the chicken or the egg?
    Brain. 2020 Dec 22. pii: 6044083. doi: 10.1093.
    >> Share

  70. KATARIA H, Hart CG, Alizadeh A, Cossoy M, et al
    Neuregulin-1 beta 1 is implicated in pathogenesis of multiple sclerosis.
    Brain. 2020 Dec 13. pii: 6032483. doi: 10.1093.
    >> Share

  71. HOHLFELD R, Beltran E, Gerdes LA, Dornmair K, et al
    Tissue-resident CD8+ memory T cells in multiple sclerosis.
    Brain. 2020 Dec 13. pii: 6032479. doi: 10.1093.
    >> Share

  72. SMOLDERS J, Fransen NL, Huitinga I, Hamann J, et al
    Reply: Tissue-resident CD8+ memory T cells in multiple sclerosis.
    Brain. 2020 Dec 13. pii: 6032480. doi: 10.1093.
    >> Share

    November 2020
  73. PETROU P, Kassis I, Levin N, Paul F, et al
    Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis.
    Brain. 2020 Nov 30. pii: 6012789. doi: 10.1093.
    >> Share

  74. PETZOLD A, Chua SYL, Khawaja AP, Keane PA, et al
    Retinal asymmetry in multiple sclerosis.
    Brain. 2020 Nov 30. pii: 6012795. doi: 10.1093.
    >> Share

  75. SCHIAVI S, Petracca M, Sun P, Fleysher L, et al
    Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosis.
    Brain. 2020 Nov 30. pii: 5999115. doi: 10.1093.
    >> Share

  76. DE MEO E, Storelli L, Moiola L, Ghezzi A, et al
    In vivo gradients of thalamic damage in paediatric multiple sclerosis: a window into pathology.
    Brain. 2020 Nov 21. pii: 5998271. doi: 10.1093.
    >> Share

  77. MARIANO R, Messina S, Roca-Fernandez A, Leite MI, et al
    Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis.
    Brain. 2020 Nov 18. pii: 5989776. doi: 10.1093.
    >> Share

  78. ELLENBERGER D, Flachenecker P, Fneish F, Frahm N, et al
    Aggressive multiple sclerosis - a matter of measurement and timing.
    Brain. 2020 Nov 11. pii: 5974108. doi: 10.1093.
    >> Share

  79. KALINCIK T, Malpas CB
    Reply: Aggressive multiple sclerosis - a matter of measurement and timing.
    Brain. 2020 Nov 11. pii: 5974107. doi: 10.1093.
    >> Share

    October 2020
  80. SUCKSDORFF M, Matilainen M, Tuisku J, Polvinen E, et al
    Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.
    Brain. 2020 Oct 2. pii: 5917253. doi: 10.1093.
    >> Share

  81. GAUDIOSO C, Naismith RT
    Optimizing treatment strategies in paediatric, adult and late-onset multiple sclerosis.
    Brain. 2020;143:2866-2868.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016